Exome sequencing identifies INPPL1 mutations as a cause of opsismodysplasia
- PMID: 23273569
- PMCID: PMC3542463
- DOI: 10.1016/j.ajhg.2012.11.015
Exome sequencing identifies INPPL1 mutations as a cause of opsismodysplasia
Abstract
Opsismodysplasia (OPS) is a severe autosomal-recessive chondrodysplasia characterized by pre- and postnatal micromelia with extremely short hands and feet. The main radiological features are severe platyspondyly, squared metacarpals, delayed skeletal ossification, and metaphyseal cupping. In order to identify mutations causing OPS, a total of 16 cases (7 terminated pregnancies and 9 postnatal cases) from 10 unrelated families were included in this study. We performed exome sequencing in three cases from three unrelated families and only one gene was found to harbor mutations in all three cases: inositol polyphosphate phosphatase-like 1 (INPPL1). Screening INPPL1 in the remaining cases identified a total of 12 distinct INPPL1 mutations in the 10 families, present at the homozygote state in 7 consanguinous families and at the compound heterozygote state in the 3 remaining families. Most mutations (6/12) resulted in premature stop codons, 2/12 were splice site, and 4/12 were missense mutations located in the catalytic domain, 5-phosphatase. INPPL1 belongs to the inositol-1,4,5-trisphosphate 5-phosphatase family, a family of signal-modulating enzymes that govern a plethora of cellular functions by regulating the levels of specific phosphoinositides. Our finding of INPPL1 mutations in OPS, a severe spondylodysplastic dysplasia with major growth plate disorganization, supports a key and specific role of this enzyme in endochondral ossification.
Copyright © 2013 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Opsismodysplasia: implications of mutations in the developmental gene INPPL1.Clin Genet. 2013 Jun;83(6):527-9. doi: 10.1111/cge.12136. Epub 2013 Mar 24. Clin Genet. 2013. PMID: 23464704 No abstract available.
Similar articles
-
Exome sequencing identifies a novel INPPL1 mutation in opsismodysplasia.J Hum Genet. 2013 Jun;58(6):391-4. doi: 10.1038/jhg.2013.25. Epub 2013 Apr 4. J Hum Genet. 2013. PMID: 23552673
-
Whole-genome analysis reveals that mutations in inositol polyphosphate phosphatase-like 1 cause opsismodysplasia.Am J Hum Genet. 2013 Jan 10;92(1):137-43. doi: 10.1016/j.ajhg.2012.11.011. Epub 2012 Dec 27. Am J Hum Genet. 2013. PMID: 23273567 Free PMC article.
-
Novel compound heterozygous mutations in inositol polyphosphate phosphatase-like 1 in a family with severe opsismodysplasia.Clin Dysmorphol. 2016 Oct;25(4):152-5. doi: 10.1097/MCD.0000000000000136. Clin Dysmorphol. 2016. PMID: 27233067 Free PMC article.
-
INPPL1 gene mutations in opsismodysplasia.J Hum Genet. 2017 Feb;62(2):135-140. doi: 10.1038/jhg.2016.119. Epub 2016 Oct 6. J Hum Genet. 2017. PMID: 27708270 Free PMC article. Review.
-
The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease.Biochem J. 2009 Apr 1;419(1):29-49. doi: 10.1042/BJ20081673. Biochem J. 2009. PMID: 19272022 Review.
Cited by
-
Suppression of SHIP2 contributes to tumorigenesis and proliferation of gastric cancer cells via activation of Akt.J Gastroenterol. 2016 Mar;51(3):230-40. doi: 10.1007/s00535-015-1101-0. Epub 2015 Jul 23. J Gastroenterol. 2016. PMID: 26201869
-
Targeting SHIP1 and SHIP2 in Cancer.Cancers (Basel). 2021 Feb 20;13(4):890. doi: 10.3390/cancers13040890. Cancers (Basel). 2021. PMID: 33672717 Free PMC article. Review.
-
Next-generation sequencing: a frameshift in skeletal dysplasia gene discovery.Osteoporos Int. 2014 Feb;25(2):407-22. doi: 10.1007/s00198-013-2443-1. Epub 2013 Aug 1. Osteoporos Int. 2014. PMID: 23903953 Review.
-
Opsismodysplasia resulting from an insertion mutation in the SH2 domain, which destabilizes INPPL1.Am J Med Genet A. 2014 Sep;164A(9):2407-11. doi: 10.1002/ajmg.a.36640. Epub 2014 Jun 20. Am J Med Genet A. 2014. PMID: 24953221 Free PMC article. No abstract available.
-
Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy.Front Pediatr. 2015 Jun 22;3:48. doi: 10.3389/fped.2015.00048. eCollection 2015. Front Pediatr. 2015. PMID: 26157786 Free PMC article.
References
-
- Zonana J., Rimoin D.L., Lachman R.S., Cohen A.H. A unique chondrodysplasia secondary to a defect in chondroosseous transformation. Birth Defects Orig. Artic. Ser. 1977;13(3D):155–163. - PubMed
-
- Maroteaux P., Stanescu V., Stanescu R. Four recently described osteochondrodysplasias. Prog. Clin. Biol. Res. 1982;104:345–350. - PubMed
-
- Maroteaux P., Stanescu V., Stanescu R., Le Marec B., Moraine C., Lejarraga H. Opsismodysplasia: a new type of chondrodysplasia with predominant involvement of the bones of the hand and the vertebrae. Am. J. Med. Genet. 1984;19:171–182. - PubMed
-
- Cormier-Daire V., Delezoide A.L., Philip N., Marcorelles P., Casas K., Hillion Y., Faivre L., Rimoin D.L., Munnich A., Maroteaux P., Le Merrer M. Clinical, radiological, and chondro-osseous findings in opsismodysplasia: survey of a series of 12 unreported cases. J. Med. Genet. 2003;40:195–200. - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
